Efficacy and safety of thalidomide in adults with refractory Crohn's disease to maintain clinical remission: a retrospective cohort study

被引:0
|
作者
Lin, L. [1 ]
Huang, Z. [1 ]
Chao, K. [1 ]
Gao, X. [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
来源
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词
D O I
10.1093/ecco-jcc/jjy222.782
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P658
引用
收藏
页码:S448 / S449
页数:2
相关论文
共 50 条
  • [41] Ustekinumab induces clinical and biological remission in biologic refractory Crohn's disease patients: A real-world belgian cohort study
    Liefferinckx, C.
    Verstockt, B.
    Gils, A.
    Noman, M.
    Van Kemseke, C.
    Macken, E.
    De Vos, M.
    Van Moerkercke, W.
    Rahier, J. -F.
    Bossuyt, P.
    Dutre, J.
    Humblet, E.
    Staessen, D.
    Peeters, H.
    Van Hootegem, P.
    Louis, E.
    Franchimont, D.
    Baert, F.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S31 - S32
  • [42] Thalidomide in refractory vulvar ulcerations associated with Crohn's disease
    Kolivras, A
    De Maubeuge, J
    André, J
    Song, M
    DERMATOLOGY, 2003, 206 (04) : 381 - 383
  • [43] Successful Use of Thalidomide for Refractory Esophageal Crohn's Disease
    Barkin, Jodie A.
    Schonfeld, Wayne B.
    Deshpande, Amar R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (05): : 855 - 857
  • [44] EFFECT OF THALIDOMIDE ON CLINICAL REMISSION IN ADULT WITH REFRACTORY CROHN DISEASE-A MULTICENTER, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL
    Zhi, Min
    Peng, Xiang
    Cao, Qian
    Gao, Xiang
    Hu, Pinjin
    GASTROENTEROLOGY, 2019, 156 (06) : S643 - S643
  • [45] Methotrexate for induction of remission in refractory Crohn's disease
    Alfadhli, AAF
    McDonald, JWD
    Feagan, BG
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01):
  • [46] Methotrexate for induction of remission in refractory Crohn's disease
    McDonald, John W. D.
    Tsoulis, David J.
    MacDonald, John K.
    Feagan, Brian G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):
  • [47] Methotrexate for induction of remission in refractory Crohn's disease
    McDonald, John W. D.
    Wang, Yongjun
    Tsoulis, David J.
    MacDonald, John K.
    Feagan, Brian G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [48] Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience
    Wils, P.
    Bouhnik, Y.
    Michetti, P.
    Flourie, B.
    Brixi, H.
    Bourrier, A.
    Allez, M.
    Duclos, B.
    Serrero, M.
    Buisson, A.
    Amiot, A.
    Fumery, M.
    Roblin, X.
    Peyrin-Biroulet, L.
    Filippi, J.
    Bouguen, G.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S43 - S43
  • [49] The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study
    Ueno, Nobuhiro
    Saito, Seisuke
    Sato, Masahiro
    Sugiyama, Yuya
    Kobayashi, Yu
    Murakami, Yuki
    Sugimura, Kohjiro
    Sasaki, Takahiro
    Sakatani, Aki
    Takahashi, Keitaro
    Tanaka, Kazuyuki
    Serikawa, Shinya
    Ando, Katsuyoshi
    Kashima, Shin
    Muto, Momotaro
    Inaba, Yuhei
    Moriichi, Kentaro
    Tanabe, Hiroki
    Okumura, Toshikatsu
    Fujiya, Mikihiro
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (03) : 442 - 452
  • [50] LONG-TERM CLINICAL EFFICACY OF USTEKINUMAB IN REFRACTORY CROHN'S DISEASE: A MULTI-CENTRE BELGIAN COHORT STUDY
    Liefferinckx, Claire
    Verstockt, Bram
    Gils, Ann
    Noman, Maja
    Van Kemseke, Catherine
    Macken, Elisabeth
    De Vos, Martine
    Van Moerkercke, Wouter
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dutre, Joris
    Humblet, Evelien
    Staessen, Dirk
    Peeters, Harald
    Van Hootegem, Philippe
    Louis, Edouard
    Franchimont, Denis
    Baert, Filip J.
    Vermeire, Severine
    GASTROENTEROLOGY, 2019, 156 (06) : S882 - S883